Partnerships
Twist Bioscience (TWST) has been doing well during the pandemic and the first 9 months of its 2020 fiscal as announced in its Q3 earnings call:
At the beginning of the fiscal year, we outlined we'll secure between five and 10 partnerships, as Emily noted, and we were tracking to do exactly that. During the quarter, we signed three new antibody discovery partnerships and expanding the agreement with a current customer.
As Emily mentioned, we've now signed total nine agreements with six generating milestones and/or royalties.
One of those agreements is even